Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors

By Makatini Maya M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 1, 2013-02 ,pp. : 78-88

Informa Healthcare

Access to resources Recommend Favorite

F99 is Critical for Dimerization and Activation of South African HIV-1 Subtype C Protease

By Naicker Previn   Seele Palesa   Dirr Heini   Sayed Yasien  

The Protein Journal, Vol. 32, Iss. 7, 2013-10 ,pp. : 560-567

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of commercial inhibitors against subtype F HIV-1 protease

By Krauchenco Sandra   Martins Nadia H.   Sanches Mario   Polikarpov Igor  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 3, 2009-06 ,pp. : 638-645

Informa Healthcare

Access to resources Recommend Favorite

Novel Azacyclic Ureas That Are Potent Inhibitors of HIV-1 Protease

By Sham H.L.   Zhao C.   Marsh K.C.   Betebenner D.A.   Lin S.   Jr W.R.   Herrin T.   Li L.   Madigan D.   Vasavanonda S.   Molla A.   Saldivar A.   McDonald E.   Wideburg N.E.   Kempf D.   Norbeck D.W.   Plattner J.J.  

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 2, 1996-08 ,pp. : 436-440

Elsevier

Access to resources Recommend Favorite

Screening of Inhibitors of HIV-1 Protease Using an Escherichia coli Cell Assay

By Buttner J.   Dornmair K.   Schramm H.J.  

Biochemical and Biophysical Research Communications, Vol. 233, Iss. 1, 1997-04 ,pp. : 36-38

Elsevier

Access to resources Recommend Favorite